Position in ARVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$257,842
-$1,261,275 QoQ
Shares Held
31,028
-78.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#102
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. ARVN ranks #223 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,842 | 31,028 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,519,117 | 143,313 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $379,459 | 31,995 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,829,915 | 214,779 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $274,666 | 37,319 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,614,731 | 372,469 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $35,600,182 | 1,857,078 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $57,370,730 | 2,329,303 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $52,227,373 | 1,961,960 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $70,169,517 | 1,699,843 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $89,433,639 | 2,172,829 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $39,068,809 | 1,989,247 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $49,595,893 | 1,998,223 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $54,979,940 | 2,012,443 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $67,298,150 | 1,967,207 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $93,073,522 | 2,092,010 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $90,939,525 | 2,160,597 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $126,517,672 | 1,879,906 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $156,315,293 | 1,903,035 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $152,537,583 | 1,856,140 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $134,127,532 | 1,741,916 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $114,418,106 | 1,730,985 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $136,986,228 | 1,612,931 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $27,259,372 | 1,154,569 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $13,150,529 | 392,085 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $646,733 | 16,048 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||